Can three-times-a-day cyclosporine neoral avoid cylosporine toxicity in renal transplant recipients? A pharmacokinetic study

被引：1
|
作者：
Swart, N [1 ]
Botha, J [1 ]
Tandon, V [1 ]
Michaels, P [1 ]
Pontin, AR [1 ]
Halkett, J [1 ]
Pascoe, MD [1 ]
Kahn, D [1 ]
机构：
[1] Univ Cape Town, Dept Surg, ZA-7925 Cape Town, South Africa
来源：
TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 7-8期
关键词：
D O I：
10.1016/S0041-1345(01)02338-7
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：3140 / 3141
页数：2
相关论文
共 16 条
  • [1] A pharmacokinetic conversion study of Abbott cyclosporine and Neoral® in stable renal transplant recipients
    Tomlanovich, S
    Pollak, R
    Roza, A
    Merion, R
    Scandling, J
    Greco, R
    Dubé, L
    Awni, W
    Nabulsi, A
    TRANSPLANTATION, 1999, 67 (07) : S163 - S163
  • [2] Decreasing side effects of Neoral through three-times-a-day protocol in Chinese renal transplant patients
    Chen, ZS
    Zeng, FJ
    Lin, ZB
    Chen, ZK
    Sha, B
    Wen, ZX
    Ming, CS
    Zhang, WJ
    Xia, SS
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3156 - 3157
  • [3] Neoral - A new microemulsion formula of cyclosporine A: Interpatient pharmacokinetic variability in renal transplant recipients
    Klauser, R
    Irschik, H
    Kletzmayr, J
    Sturm, I
    Brunner, W
    Woloszczuk, W
    Kovarik, J
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (06) : 3427 - 3429
  • [4] Population pharmacokinetic study of cyclosporine in Chinese renal transplant recipients
    Bing Chen
    WeiXia Zhang
    ZhiDong Gu
    Juan Li
    YuXin Zhang
    WeiMin Cai
    European Journal of Clinical Pharmacology, 2011, 67 : 601 - 612
  • [5] Population pharmacokinetic study of cyclosporine in Chinese renal transplant recipients
    Chen, Bing
    Zhang, WeiXia
    Gu, ZhiDong
    Li, Juan
    Zhang, YuXin
    Cai, WeiMin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (06) : 601 - 612
  • [6] Pharmacokinetic, blood pressure, and renal effects of cyclosporine Sandimmune vs Neoral formulation in heart transplant recipients
    White, M
    Pelletier, GB
    Jesina, C
    Carrier, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 86178 - 86178
  • [7] Pharmacokinetic cyclosporine A profiles under long-term Neoral treatment in renal transplant recipients: Does fat intake still matter?
    Klauser, RM
    Irschik, H
    Kletzmayr, J
    Sturm, I
    Brunner, W
    Woloszczuk, W
    Kovarik, J
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (07) : 3137 - 3140
  • [8] Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients - A report of the Canadian Neoral Renal Study Group
    Cole, E
    Keown, P
    Landsberg, D
    Halloran, P
    Shoker, A
    Rush, D
    Jeffrey, J
    Russell, D
    Stiller, C
    Muirhead, N
    Paul, L
    Zaltzman, J
    Loertscher, R
    Daloze, P
    Dandavino, R
    Boucher, A
    Handa, P
    Lawen, J
    Belitsky, P
    Parfrey, P
    Tan, A
    Hendricks, L
    TRANSPLANTATION, 1998, 65 (04) : 505 - 510
  • [9] INCREASED CYCLOSPORINE LEVELS AS A RESULT OF SIMULTANEOUS FLUCONAZOLE AND CYCLOSPORINE THERAPY IN RENAL-TRANSPLANT RECIPIENTS - A DOUBLE-BLIND, RANDOMIZED PHARMACOKINETIC AND SAFETY STUDY
    CANAFAX, DM
    GRAVES, NM
    HILLIGOSS, DM
    CARLETON, BC
    GARDNER, MJ
    MATAS, AJ
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 1041 - 1042
  • [10] Effect of plasma uric acid on pharmacokinetics of cyclosporine A in living-related renal transplant recipients and pharmacokinetic study in rats with experimental hyperuricaemia
    Sugioka, N.
    Takai, M.
    Yoshida, K.
    Yasuda, K.
    Fukushima, K.
    Kokuhu, T.
    Okamoto, M.
    Yoshimura, N.
    Takada, K.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (03) : 323 - 332
12